Insights
Product updates from Medicup, plus healthcare technology news curated from trusted outlets — CDC, FDA, and leading health-tech publications.
Amid a healthcare workforce crisis, a new paper from Cleveland Clinic shows that using AI-powered ambient scribes is paying off in clinician satisfaction and retention, validating a core principle of digital-first care.
As AI becomes a key tool in crisis response, new questions arise about power, governance, and accountability. A commentary in The Lancet Digital Health urges the global health community to build frameworks that ensure this technology serves humanity equitably and safely.
Humanitarian aid is facing critical shortfalls. New research highlights how AI could optimize resource distribution, but only if we navigate the serious ethical challenges first.
Imagine your doctor asking a chatbot, "What are this patient's latest lab results?" and getting an instant, accurate summary. This isn't science fiction; it's happening now.
In the fight against cancer, a critical question is being raised: could patients be receiving too much medication? Exploring the push for optimized, patient-specific dosing over the traditional 'maximum tolerated dose' approach.
The U.S. Food and Drug Administration has officially begun exploring how to regulate generative AI, a move that could build trust and ensure safety for new digital health tools.
Electronic health record (EHR) giant Epic is facing a federal antitrust probe. At the same time, it's rolling out a new wave of AI tools. Here's why this matters for the future of digital health.
The FDA has released new draft guidance on using digital health technologies like wearables in clinical research, emphasizing that devices must be validated and measure outcomes that are meaningful to patients.
Major insurer Humana has hired Dr. Shantanu Nundy, a physician with deep experience in AI and patient navigation. Here's why this executive move signals a major shift for the future of your healthcare.
A major acquisition in the healthcare tech world signals a big push toward using artificial intelligence to automate and speed up the often-frustrating process of getting medical procedures preapproved by insurers.
Artificial intelligence is increasingly used to monitor drug safety after medications hit the market. But as this technology becomes more common, the key to its success—and to patient safety—lies in strong governance and accountability.
CVS Health is bringing JPMorgan's data and analytics chief onto its board, signaling a major investment in AI and data-driven healthcare that will have ripple effects for patients and providers alike.
